Arsenicin A, A Natural Polyarsenical: Synthesis and Crystal Structure

  title={Arsenicin A, A Natural Polyarsenical: Synthesis and Crystal Structure},
  author={Di-Qiu Lu and Alan David Rae and Geoffrey Salem and Michelle L Weir and Anthony C. Willis and Stanley Bruce Wild},
The synthesis of the natural polyarsenical Arsenicin A and its crystal structure are described. The molecule has the adamantane-type structure of arsenic trioxide in which three of the oxygen atoms have been replaced by methylene groups to generate four arsenic stereocenters of the same configuration in each enantiomer of the racemate. 

Figures from this paper

Computing the NMR spectra of the sponge metabolite arsenicin A: when simple becomes difficult
Determining the structure of the natural polyarsenical arsenicin A has proved difficult, but computational chemistry has played a decisive role in the process. This paper aims at tracing the winding
Commentary on the Synthesis and Structures of Unsupported Cycloarsoxane Compounds
This comment describes the available synthetic routes and some general structural features of unsupported cycloarsoxane compounds. The key synthetic strategies used to prepare this type of compound
Sulfur Derivatives of the Natural Polyarsenical Arsenicin A: Biologically Active, Organometallic Arsenic–Sulfur Cages Related to the Minerals Realgar and Uzonite
The theoretical contribution was supported by the Australian Research Council (ARC) and the Australian National Computational Infrastructure. M.L.C. gratefully acknowledges the award of an ARC
Origin of the unusual ultraviolet absorption of Arsenicin A.
Experiments and theoretical investigations reveal that this molecule strongly absorbs UV light in the absence of an obvious chromophore, and that the absorption is facilitated by through-space and through-bond interactions, between the lone pairs on the arsenic and oxygen atoms and the σ-bonding framework of the molecule.
Arsenic Halogenation of 9-Arsafluorene and Utilization for As–C Bond Formation Reaction
A practical arsenic halogenation of 9-arsafluorene, which can be safely and easily prepared from a cyclooligoarsine, was developed by using halogen sources such as iodine and iodine monochloride. The
Synthesis and in-vitro anticancer evaluation of polyarsenicals related to the marine sponge derived Arsenicin A
From in vitro screening, each tested compound resulted in being more active than the FDA-approved arsenic trioxide, with the most lipophilic molecule in the series showing the best growth inhibition of both leukemia and solid tumor cell lines.
Bioactive poly(arsenic) compounds.
An overview of the biological activities of arsenic compounds containing more than one arsenic atom in their molecular structure is presented. This contribution covers the literature of the last
Resolution and improved synthesis of (±)-arsenicin A: A natural adamantane-type tetraarsenical possessing strong anti-acute promelocytic leukemia cell line activity
The resolution and improved synthesis of the naturally occurring, adamantane-type, tetraarsenical (±)-Arsenicin A is reported. The five-step synthesis of (±)-Arsenicin A from
Chemoenzymatic and enantiodivergent routes to 1,2-ring-fused bicyclo[2.2.2]octane and related tricyclic frameworks.
New and simple protocols are described for the conversion of the enzymatically-derived and enantiomerically pure cis-1,2-dihydrocatechol (X = I) and its 6-methylated derivative into either antipodal


Computational NMR spectroscopy of organoarsenicals and the natural polyarsenic compound arsenicin A.
It is shown that non-relativistic methods successfully model the NMR spectra of (1)H and (13)C NMR chemical shifts and coupling constants of a series of organoarsenic compounds, and application of the same methods to arsenicin A allowed several viable alternative structures to be ruled out and confirmed the previously suggested adamantane-like structure of arsenic in A.
On the first polyarsenic organic compound from nature: arsenicin A from the New Caledonian marine sponge Echinochalina bargibanti.
In defining an adamantine-type polyarsenic structure for this compound, deceptively simple NMR spectra were complemented by extensive mass spectral analysis and a comparative ab initio simulation of IR spectra for the natural and the synthetic compounds was decisive.
Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release.
The results demonstrate that cytotoxicity can be controlled via transitions of the inorganic drug between solid and solution phases and suggest a mechanism for further improvement of the risk/benefit ratio of As2O3 in treatment of a variety of cancers.
Mechanisms of action of arsenic trioxide.
Substantial data show that arsenic trioxide produces remissions in patients with APL at least in part through a mechanism that results in the degradation of the aberrant PML-retinoic acid receptor alpha fusion protein.
Zur Kenntnis des Methan‐diarsenoxids. I
Sublimiertes Methan-diarsenoxid, das bei der Hydrolyse von Methan-bis-dichlorarsin entsteht, liegt in Benzol-Losungen in dimerem Zustand als (CH2As2O2)2 vor und zeigt formale Ahnlichkeit mit dem
Darstellung und Reaktion des Chlormethyl-dichlorarsins
Chlormethyl-dichlorarsin, ClCH2AsCl2, wird dargestellt durch Alkylieren von AsCl3 mit Bis-chlormethyl-quecksilber und durch Kommutieren von Chlormethyl-diphenyl-arsin mit AsCl3 bei 270°C. Mit
710 73 Å ; 14 095 reflections collected
    5°; absorption corrected by integration via Gaussian method implemented in maXus (2000); refinement method full-matrix least squares on F 2